Skip to content

Cerus CERS Other income, net (Note 6)

Other income, net (Note 6) at other companies

Haemonetics logo
HaemoneticsHAE
-$5.37M-799%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$53K-35.4%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$3.4M+343%
ADMA Biologics logo
ADMA BiologicsADMA
-$140K-119%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's other income, net (note 6)?
Cerus (CERS) reported other income, net (note 6) of $519K in Q1 2026.
How has Cerus's other income, net (note 6) changed year-over-year?
Cerus's other income, net (note 6) decreased by 14.4% year-over-year, from $606K to $519K.
What is the long-term trend for Cerus's other income, net (note 6)?
Over 3 years (2022 to 2025), Cerus's other income, net (note 6) has grown at a 20.2% compound annual growth rate (CAGR), from -$1.74M to $3.02M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.